COMET-AOA: Median Nerve Stiffness in Mild-Moderate CTS With OMT & Conservative Therapy
COMET-AOA
Pilot Study Evaluating the Elasticity and Shear Wave Modulus (Stiffness) of the Median Nerve in Patients With Mild to Moderate Idiopathic Carpal Tunnel Syndrome Receiving OMT and Conservative Therapy
1 other identifier
interventional
10
1 country
1
Brief Summary
To evaluate and quantify changes in the elasticity and shear wave modulus (stiffness) of the median nerve in patients diagnosed with mild to moderate carpal tunnel syndrome following osteopathic manipulative therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2023
CompletedFirst Posted
Study publicly available on registry
November 29, 2023
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFebruary 25, 2026
March 1, 2024
12 months
November 14, 2023
February 23, 2026
Conditions
Outcome Measures
Primary Outcomes (6)
Elasticity of median nerve at the carpal tunnel inlet
Measured by shear wave elastography.
baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment
Cross-sectional area of median nerve in 3 locations
Measured by real-time grayscale ultrasound
baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment
Quick DASH Patient Survey Score
This questionnaire asks the patient about their symptoms as well as their ability to perform certain activities. The QuickDASH, published in 2005 in the Journal of Bone and Joint Surgery, is a subset of 11 items from the 30-item DASH and is a self-reported questionnaire in which the response options are presented as 5-point Likert scales. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability). This score was designed be useful in patients with any musculoskeletal disorder of the upper limb.
Completed at treatment visits (initial, 2 weeks, 4 weeks, and 6 weeks)
CTS-6 Evaluation Tool Score
The Value Added by Electrodiagnostic Testing in the Diagnosis of Carpal Tunnel Syndrome completed by the clinician. A score \>12 = 0.80 probability of Carpal Tunnel Syndrome and a score \>5 = 0.25 probability of Carpal Tunnel Syndrome.
Completed at treatment visits (initial, 2 weeks, 4 weeks, and 6 weeks)
Elasticity of the transverse carpal ligament
Measured by shear wave elastography.
baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment
Elasticity of the subsynovial connective tissue in the carpal tunnel
Measured by shear wave elastography.
baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment
Secondary Outcomes (2)
Motor Distal Latency
Baseline and at 8 weeks (end of study)
Sensory Distal Latency
Baseline and at 8 weeks (end of study)
Study Arms (3)
Group 1 - OMT Only
EXPERIMENTALOsteopathic manipulative treatment will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. The cervical spine will also be treated, with particular attention to the C5-7 levels, all the way to the wrist and hand as the physician sees fit based on the findings of the osteopathic structural exam.
Group 2 - OMT + Conservative Treatment
ACTIVE COMPARATORWill receive Osteopathic manipulative treatment in addition to conservative treatment. Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical and Occupational therapy will be excluded from the conservative therapy regimen. Osteopathic manipulative treatment will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. The cervical spine will also be treated, with particular attention to the C5-7 levels, all the way to the wrist and hand as the physician sees fit based on the findings of the osteopathic structural exam.
Group 3 - Conservative Treatment Only
ACTIVE COMPARATORConservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical and Occupational therapy will be excluded from the conservative therapy regimen.
Interventions
Two osteopathic primary care physicians will performing osteopathic manipulative techniques with a minimum of three direct techniques focused on carpal tunnel. These techniques will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. They will also evaluate and treat the cervical spine, with particular attention to the C5-7 levels, all the way to the wrist and hand as they see fit based on the findings of their osteopathic structural exam.
Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical therapy will be excluded from the conservative therapy regimen.
Eligibility Criteria
You may qualify if:
- Diagnosis of unilateral or bilateral mild to moderate carpal tunnel syndrome, based on recent EMG findings
You may not qualify if:
- History of undergoing recent physical therapy for treatment of carpal tunnel syndrome
- History of wrist trauma or surgery
- Hypothyroidism
- Severe CTS that has progressed to muscle atrophy
- Systemic disease or condition including but not limited to diabetes mellitus, thyroid disorders, rheumatoid disorders, Paget's bone disease, gout, myxedema, multiple myeloma, acromegaly, hepatic disease, dialysis patients, or other diseases or conditions in which peripheral neuropathies are common.
- Secondary cause of CTS such as a ganglion cyst, mass, or an accessory muscle shown by US or MRI of the affected wrist.
- Bifid median nerve as shown by US or MRI of the affected wrist
- pregnant or recently postpartum
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- American Osteopathic Associationcollaborator
- Kettering Health Networklead
Study Sites (1)
Kettering Health
Dayton, Ohio, 45458, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roland Gazaille, DO
Kettering Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2023
First Posted
November 29, 2023
Study Start
April 1, 2024
Primary Completion
March 31, 2025
Study Completion
June 1, 2025
Last Updated
February 25, 2026
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share